- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05627492
Pragmatic Patient-oriented Extension Study of Dialectical Behavior Therapy Booster Sessions for Youth With and/or at Familial Risk for Bipolar Disorder (DB2)
November 17, 2025 updated by: Benjamin Goldstein, Centre for Addiction and Mental Health
The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder.
Participants will have completed one full year of DBT in a previous study.
This study is examining use of booster sessions.
It is delivered in the form of individual sessions and skills sessions, based on the preference of the study participant.
The study participant may also receive skills coaching via phone.
There is no standard reference therapy/comparator against which the study intervention is being compared.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study intervention is DBT adapted for youth with and/or at familial risk for bipolar disorder.
Participants will have completed one full year of DBT in a previous study.
This study is examining use of booster sessions.
It is delivered in the form of individual sessions and skills sessions, based on the preference of the study participant.
The study participant may also receive skills coaching via phone.
DBT consists of four components: individual therapy sessions, skills sessions, skills coaching via phone, and consultation team.
Given this study is an extension of an existing study of full DBT, the proposed intervention is not prescriptive; that is, we have opted not to dictate how many sessions participants will receive and/or when.
Instead, we have opted to leave this decision for participants and their treatment providers to reach collaboratively.
Participants, in consultation with their study therapist, will select the frequency of their booster sessions.
This may include individual and/or skills sessions in addition to phone coaching for those who attend individual sessions at least once per month.
DBT consultation will also remain a component of the treatment.
This level of intervention seems appropriate, given that participants have completed a full year of DBT and thus may require a less intensive treatment for continued care.
Moreover, it is important to give youth autonomy in treatment options to model health decision making for other life choices.
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amanda Moss, MSW
- Phone Number: 33227 416-535-8501
- Email: amanda.moss@camh.ca
Study Contact Backup
- Name: Vanessa Rajamani, MSW
- Phone Number: 31761 416-535-8501
- Email: vanessa.rajamani@camh.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6J 1H4
- Recruiting
- Centre for Addiction and Mental Health
-
Contact:
- Amanda Moss, MSW
- Phone Number: 33227 416-535-8501
- Email: amanda.moss@camh.ca
-
Principal Investigator:
- Benjamin I Goldstein, MD, PhD
-
Contact:
- Vanessa Rajamani, MSW
- Phone Number: 31761 416-535-8501
- Email: vanessa.rajamani@camh.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 25 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria
The participant must meet all of the inclusion criteria to eligible for this clinical trial:
- Has completed participation in the DB1 study (049-2021) or the DB3 study (009-2021);
- English speaking;
- Age 14 years, 0 months to 26 years, 11 months;
- Meets diagnostic criteria for bipolar disorder by KSADS-PL(< 20 years of age) OR SCID-5-RV (≥ 20 years of age) OR have a biological parent/sibling with BD (type I or II) confirmed via KSADS-PL or SCID-5-RV;
- Followed by a psychiatrist who provides ongoing care;
- If BD-I, taking ≥1 mood stabilizing medication (i.e., antimanic anticonvulsant, antipsychotic, and/or lithium);
- Able and willing to give informed consent/assent to participate.
Exclusion Criteria
An individual who meets any of the following criteria will be excluded from participation in this clinical trial:
- A life-threatening medical condition requiring immediate treatment;
- Current victim of sexual or physical abuse;
- Current substance use disorder other than mild cannabis or alcohol use disorder;
- Evidence of mental retardation, moderate to severe autism spectrum disorder, or organic central nervous system disorder by the K-SADS-PL, parent report, medical history, or school records that would interfere with active participation in DBT.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Youth with and/or at familial risk for bipolar disorder
120 youth aged 14 to 26 with bipolar disorder (type I, type II, not otherwise specified/NOS via KSADS-PL or SCID-5-RV) OR at high-risk for bipolar disorder (parent or sibling with bipolar disorder type I or II via KSADS-PL or SCID-5-RV) will be enrolled in the dialectical behavioral therapy booster session intervention.
|
DBT will be conducted over 2 years.
Participants and their treatment providers will decide on the frequency of sessions collaboratively.
This may include individual and/or skills sessions in addition to phone coaching for those who attend individual sessions at least once per month.
DBT consultation will also remain a component of the treatment.
Participants may choose skills training, conducted in approximately 60 minute meetings, and individual therapy conducted in approximately 60 minute sessions.
Family participation in skills training is highly encouraged.
Skills training may include: psychoeducation, mindfulness skills, emotion regulation skills, distress tolerance skills, interpersonal skills, and walking the middle path skills.
Individual therapy sessions aim to aid the youth in applying skills in their daily lives.
We adopt the standard DBT hierarchy of treatment targets.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total number of DBT sessions used during the study interval measured using the Therapy Tracking Form
Time Frame: At the end of study completion (five years)
|
The Therapy Tracking Form will be used to document the date of the therapy session, type of session, session duration, content, and scheduled date for next therapy visit.
This form will be completed by the study therapist after each therapy session.
|
At the end of study completion (five years)
|
|
Number of unscheduled/expedited DBT sessions that are required measured using the Therapy
Time Frame: At the end of study completion (five years)
|
The Therapy Tracking Form will be used to document if the session was a scheduled session or an unscheduled/expedited session.
This form will be completed by the study therapist after each therapy session.
|
At the end of study completion (five years)
|
|
Frequencies of different factors/circumstances leading to the need for unscheduled/expedited DBT sessions measured using the Therapy
Time Frame: At the end of study completion (five years)
|
The Therapy Tracking Form will be used to document the reason for the unscheduled/expedited DBT session.
This form will be completed by the study therapist after each therapy session.
|
At the end of study completion (five years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequencies of specific DBT components (individual sessions, skills session, phone coaching) measured using the Therapy Tracking Form
Time Frame: At the end of study completion (five years)
|
The Therapy Tracking Form will be used to document the type of therapy session and phone coaching use.
This form will be completed by the study therapist after each therapy session.
|
At the end of study completion (five years)
|
|
Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder
Time Frame: 12 months to 18 months
|
Borderline and antisocial personality symptoms will be assessed using the Structured Interview for DSM-IV Personality.
The SID-P uses a semi structured interview format to assess for symptoms of personality disorders.
Scores one each item range from 0 to 3 and high scores indicate symptoms of borderline personality disorder and levels of impairment.
|
12 months to 18 months
|
|
Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder
Time Frame: 18 months to 24 months
|
Borderline and antisocial personality symptoms will be assessed using the Structured Interview for DSM-IV Personality.
The SID-P uses a semi structured interview format to assess for symptoms of personality disorders.
Scores one each item range from 0 to 3 and high scores indicate symptoms of borderline personality disorder and levels of impairment.
|
18 months to 24 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 12 months to 15 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
12 months to 15 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 15 months to 18 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
15 months to 18 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 18 months to 21 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
18 months to 21 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 21 months to 24 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
21 months to 24 months
|
|
Change in symptoms using the Adolescent Longitudinal Interval Follow-up Evaluation (ALIFE)
Time Frame: 12 months to 18 months
|
The Longitudinal Interval Follow-up Evaluation (LIFE) will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study.
Scores range from 0-3 on certain disorders and 0-6 for other disorders.
High scores indicate high level of symptom impairment.
|
12 months to 18 months
|
|
Change in symptoms using the Adolescent Longitudinal Interval Follow-up Evaluation (ALIFE)
Time Frame: 18 months to 24 months
|
The Longitudinal Interval Follow-up Evaluation (LIFE) will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study.
Scores range from 0-3 on certain disorders and 0-6 for other disorders.
High scores indicate high level of symptom impairment.
|
18 months to 24 months
|
|
Change in suicidality using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 12 months to 18 months
|
Suicidal events (past and over follow-up) will be assessed with the Pediatric Version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
The C-SSRS has sound psychometric properties, yields ratings of widely accepted definitions of youth suicidal events, and was used in other pediatric treatment trials yielding standardized outcomes to compare across studies.
This is a semi-structured interview that includes yes/no questions as well as narrative.
It captures number of suicidal events as well as type and severity.
|
12 months to 18 months
|
|
Change in suicidality using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 18 months to 24 months
|
Suicidal events (past and over follow-up) will be assessed with the Pediatric Version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
The C-SSRS has sound psychometric properties, yields ratings of widely accepted definitions of youth suicidal events, and was used in other pediatric treatment trials yielding standardized outcomes to compare across studies.
This is a semi-structured interview that includes yes/no questions as well as narrative.
It captures number of suicidal events as well as type and severity.
|
18 months to 24 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 12 months to 15 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
12 months to 15 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 15 months to 18 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
15 months to 18 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 18 months to 21 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
18 months to 21 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 21 months to 24 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
21 months to 24 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 15 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
15 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 18 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
18 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 21 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
21 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 24 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
24 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 12 months to 15 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
12 months to 15 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 15 months to 18 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
15 months to 18 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 18 months to 21 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
18 months to 21 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 21 months to 24 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
21 months to 24 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 12 months to 15 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
12 months to 15 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 15 months to 18 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
15 months to 18 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 18 months to 21 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
18 months to 21 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 21 months to 24 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
21 months to 24 months
|
|
Adherence score for DBT booster sessions measured using a modified version of the Dialectical Behavior Therapy Adherence Checklist - Individual Therapy
Time Frame: At the end of study completion (five years)
|
Video recordings will be rated for adherence using a modified version of the Dialectical Behavior Therapy Adherence Checklist - Individual Therapy (DBT AC-I) [54].
The 12 DBT strategy domains will be rated as yes/no: 1) structural strategies; 2) problem assessment strategies; 3) problem solving strategies; 4) contingency management strategies; 5) exposure strategies; 6) cognitive modification strategies; 7) validation strategies; 8) reciprocal communication strategies; 9) irreverent communication strategies; 10) dialectical strategies; 11) case management strategies; 12) protocols.
|
At the end of study completion (five years)
|
|
Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder
Time Frame: 24 months to 30 months
|
Borderline and antisocial personality symptoms will be assessed using the Structured Interview for DSM-IV Personality.
The SIDP uses a semi structured interview format to assess for symptoms of personality disorders.
Scores one each item range from 0 to 3 and high scores indicate symptoms of borderline personality disorder and levels of impairment.
|
24 months to 30 months
|
|
Change in symptoms using the Structured Interview for DSM-IV Personality Disorders (SIDP-IV): Borderline Personality Disorder
Time Frame: 30 months to 36 months
|
Borderline and antisocial personality symptoms will be assessed using the Structured Interview for DSM-IV Personality.
The SIDP uses a semi structured interview format to assess for symptoms of personality disorders.
Scores one each item range from 0 to 3 and high scores indicate symptoms of borderline personality disorder and levels of impairment.
|
30 months to 36 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 24 months to 27 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
24 months to 27 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 27 months to 30 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
27 months to 30 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 30 months to 33 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
30 months to 33 months
|
|
Change in suicidality using the Suicidal Ideation Questionnaire (SIQ)
Time Frame: 33 months to 36 months
|
Youth participants will complete the self-report Suicidal Ideation (SIQ), which is intended to identify participants whose level of suicidal ideation is severe enough to warrant further intervention.
Each item is rated on a 7-point Likert-type scale (0= "I never had this thought" to 6="almost every day") and is used to indicate the frequency with which the participant experiences each thought.
|
33 months to 36 months
|
|
Change in symptoms using the Adolescent Longitudinal Interval Follow-up Evaluation (ALIFE)
Time Frame: 24 months to 30 months
|
The Longitudinal Interval Follow-up Evaluation (LIFE) will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study.
Scores range from 0-3 on certain disorders and 0-6 for other disorders.
High scores indicate high level of symptom impairment.
|
24 months to 30 months
|
|
Change in symptoms using the Adolescent Longitudinal Interval Follow-up Evaluation (ALIFE)
Time Frame: 30 months to 36 months
|
The Longitudinal Interval Follow-up Evaluation (LIFE) will provide a comprehensive cross-sectional and longitudinal picture of the symptomatic and psychosocial course and outcome of all participants in this study.
Scores range from 0-3 on certain disorders and 0-6 for other disorders.
High scores indicate high level of symptom impairment.
|
30 months to 36 months
|
|
Change in suicidality using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 24 months to 30 months
|
Suicidal events (past and over follow-up) will be assessed with the Pediatric Version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
The C-SSRS has sound psychometric properties, yields ratings of widely accepted definitions of youth suicidal events, and was used in other pediatric treatment trials yielding standardized outcomes to compare across studies.
This is a semi-structured interview that includes yes/no questions as well as narrative.
It captures number of suicidal events as well as type and severity.
|
24 months to 30 months
|
|
Change in suicidality using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Time Frame: 30 months to 36 months
|
Suicidal events (past and over follow-up) will be assessed with the Pediatric Version of the Columbia-Suicide Severity Rating Scale (C-SSRS).
The C-SSRS has sound psychometric properties, yields ratings of widely accepted definitions of youth suicidal events, and was used in other pediatric treatment trials yielding standardized outcomes to compare across studies.
This is a semi-structured interview that includes yes/no questions as well as narrative.
It captures number of suicidal events as well as type and severity.
|
30 months to 36 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 24 months to 27 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
24 months to 27 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 27 months to 30 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
27 months to 30 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 30 months to 33 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
30 months to 33 months
|
|
Change in emotion regulation using the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: 33 months to 36 months
|
Youth participants will complete the Difficulties in Emotion Regulation (DERS), a 36-item questionnaire assessing emotional dysregulation.
Participants indicate how often each item applies to them on a scale from 1="almost never; 0-10 percent" to 5= "almost always; 91-100 percent".
|
33 months to 36 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 24 months to 27 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
24 months to 27 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 27 months to 30 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
27 months to 30 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 30 months to 33 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
30 months to 33 months
|
|
Treatment Satisfaction Questionnaire (18-item)
Time Frame: 33 months to 36 months
|
During follow-up visits, participants, parents, and/or siblings who are participating in therapy sessions will complete an 18-item Treatment Satisfaction Questionnaire.
This assesses clients' satisfaction of the service (responses range from quite dissatisfied to very satisfied) as well as whether or not the service addressed the clients' needs.
|
33 months to 36 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 24 months to 27 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
24 months to 27 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 27 months to 30 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
27 months to 30 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 30 months to 33 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
30 months to 33 months
|
|
Change in use of DBT skills with the DBT Ways of Coping Checklist (DBT-WCCL)
Time Frame: 33 months to 36 months
|
Youth participants will complete the DBT-WCCL, a 59-item questionnaire assessing the use of DBT skills and coping strategies.
Participants indicate how often they engaged in the thought/behavior from 0= "never used" to 3= "regularly used".
|
33 months to 36 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 24 months to 27 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
24 months to 27 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 27 months to 30 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
27 months to 30 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 30 months to 33 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
30 months to 33 months
|
|
Change in temperament using the Conflict Behavior Questionnaire (CBQ)
Time Frame: 33 months to 36 months
|
The Conflict Behavior Questionnaire (CBQ) is a youth and parent 20-item self-report instrument that taps into conflict and negative communication between parents and their children.
Items are rated as "true" or "false".
Higher scores indicate greater levels of conflict and negative communication.
|
33 months to 36 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Benjamin I Goldstein, MD, PhD, Centre for Addiction and Mental Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 9, 2022
Primary Completion (Estimated)
November 30, 2028
Study Completion (Estimated)
November 30, 2028
Study Registration Dates
First Submitted
November 17, 2022
First Submitted That Met QC Criteria
November 17, 2022
First Posted (Actual)
November 25, 2022
Study Record Updates
Last Update Posted (Estimated)
November 19, 2025
Last Update Submitted That Met QC Criteria
November 17, 2025
Last Verified
November 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 099/2022
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.